Page last updated: 2024-08-24

ranitidine bismuth citrate and bismuth

ranitidine bismuth citrate has been researched along with bismuth in 165 studies

Research

Studies (165)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	77 (46.67)	18.2507
2000's	82 (49.70)	29.6817
2010's	4 (2.42)	24.3611
2020's	2 (1.21)	2.80

Authors

Authors	Studies
Fraser, A; Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM	1
Ciociola, AA; Goodwin, BB; Perschy, TB; Webb, DD	1
Frazer, NM; Keene, ON; Lacey, LF; Smith, JT	1
Bedding, AW; Farr, SJ; Forster, ER; Parikh, R; Smith, JT; Sweetland, J	1
Cole, AT; Hawkey, CJ; Hudson, N; Lettis, S; Murray, FE; Turnbull, GM	1
Campbell, CJ; Clayton, NM; Clitherow, JW; Grinham, CJ; McColm, AA; McLaren, A; Stables, R; Trevethick, MA	1
Fraser, AG; Hudson, M; Lam, WM; Luk, YW; Pounder, RE; Samloff, IM; Sawyerr, AM; Sercombe, J	1
Fraser, AG; Lewin, JF; Pounder, RE	1
Bardhan, KD; Dekkers, CP; Forster, JK; Kler, L; Lacey, LF; Lam, SK; Nowak, A; Schaffalitzky de Muckadell, OB; Schutze, K; Tildesley, G	1
Campbell, CJ; Connolly, PC; Francis, MR; Grinham, CJ; Klinkert, G; McColm, AA; McLaren, A; Selway, S; Williamson, R	1
Ciociola, AA; McSorley, DJ; Peterson, WL; Sykes, DL; Webb, DD	1
Webb, DD	1
Dixon, JS; Drake, FM; Tillman, LA; Wood, JR	1
Bardhan, KD; Buckley, MJ; De Koster, EH; Duggan, AE; Gilvarry, J; Gummett, PA; Logan, RP; O'Morain, CA; Pounder, RE; Rauws, EA; Schaufelberger, HD; Wyeth, JW	1
Davis, IM; Gooding, AE; Koch, KM; Yin, Y	1
Davis, IM; Gooding, AE; Kerr, BM; Koch, KM	1
Ciociola, AA; Heath, A; Walsh, JH; Webb, DD	1
Harris, A; Misiewicz, JJ	1
Axon, AT; Ireland, A; Rooprams, PD; Smith, MJ	1
Lambert, JR; Midolo, P	1
Pounder, RE; Williams, MP	1
Pounder, RE	1
Bardhan, KD; Dallaire, C; Duggan, AE; Eisold, H	1
Bisso, G; Caroli, M; Celle, G; Mansi, C; Mela, GS; Mele, MR; Olivieri, A; Saggioro, A; Savarino, V; Termini, R; Tosatto, R; Vigneri, S	1
Hamilton, MR; Pounder, RE; Sercombe, JC; Williams, MP	1
Bennett, JE; Lacey, LF; Wakefield, JC	1
Donnelly, C; McDowell, S; McLaren, A; Williamson, R	1
Dixon, JS; Mills, JG; Pipkin, GA; Wood, JR	1
Fennerty, MB	1
Pipkin, GA; Williamson, R; Wood, JR	2
Bardhan, KD; Jahnsen, J; Lotay, N; Marcelino, M; Roberts, PM; Wurzer, H	1
Scheen, AJ	1
Canena, J; Leitão, J; Pinheiro, T; Pinto, AS; Quina, MG; Reis, J; Santos, AM	1
Bazzoli, F; Cardelli, A; Catalano, FA; Giglio, A; Lami, F; Olivieri, A; Pilotto, A; Pozzato, P; Roda, E; Scarpulla, G; Spadaccini, A; Susi, D; Tosatto, R; Zagari, M	1
Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA	1
de Boer, WA; Haeck, PW; Mulder, CJ; Otten, MH	1
Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M	1
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianei, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, A; Gasbarrini, G; Papa, A; Tursi, A	1
Carvalho, AF; Da Silva, CM; De Nucci, G; Ferraz, JG; Fiorelli, LA; Jorge, VN; Pedrazzoli, J	1
Bentivegna, C; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Condorelli, G	1
Di Matteo, G; Dobrilla, G; Dodero, M; Fina, P; Fratton, A; Iaquinto, G; Loriga, P; Marchi, S; Marzio, L; Muratori, R; Olivieri, A; Pacini, D; Saggioro, A; Savarino, V; Spinelli, P; Tosatto, R; Zamboni, G	1
Kleibeuker, JH; Kooy, A; Thijs, JC; van der Wouden, EJ; van Zwet, AA	1
Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY	1
Ciociola, AA; Heath, A; Lanza, FL; McSorley, DJ; Sontag, SJ; Sykes, DL	1
Alarcón, T; Domingo, D; López-Brea, M; Prieto, N; Sánchez, I	1
Bardhan, KD; Duggan, AE; Gudjonsson, H; Hoie, O; Kliebe-Frisch, C; Kristensen, ES; Pipkin, GA; Schuetz, E	1
Barnett, J; Chey, WD; Delvalle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Palaniappan, J; Scheiman, J	1
Biagini, R; Bilardi, C; Bisso, G; Celle, G; Mansi, C; Mele, MR; Pivari, M; Savarino, V; Termini, R; Vigneri, S; Zentilin, P	1
Choi, CH; Kung, NN; Lai, WM; Lam, KN; Leung, EM; Li, TH; Lui, YH; Ng, PW; Sung, JJ; Yuen, NW	1
Attili, AF; De Francesco, V; Faleo, D; Hassan, C; Rinaldi, V; Stoppino, V; Winn, S; Zullo, A	1
Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Osato, MS; Qureshi, W	1
Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA	1
Fennerty, MB; Kelly, C; Knigge, K; Peterson, WL	1
Ashktorab, H; Hinds, T; Jagtap, J; Kim, KS; Scott, VF; Smoot, DT	1
Alarcón, T; Domingo, D; López-Brea, M; Prieto, N	1
Cave, DR; Hoffman, JS; Katz, LM	1
Bang, CJ; Berstad, A; Coll, P; Hatlebakk, JG; Hausken, T; Nysaeter, G; Olafsson, S; Olafsson, T; Tefera, S	1
Hirschowitz, BI; Mönkemüller, KE	1
Cutler, A; Vakil, N	1
Gisbert, JP; Pajares, JM; Valle, J	1
McSorley, DJ; Perschy, TB; Schwartz, HI; Sorrells, SC	1
Karim, QN; Sidebotham, RL; Worku, ML	1
Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M	1
Lichtenberger, LM; Ottlecz, A; Romero, JJ	1
Bardhan, KD; Farley, A; French, PC; Paré, P; Roberts, PM; Romãozinho, JM	1
Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC	1
Chippendale, GR; Garner, RM; Gilbert, JV; Kane, AV; Mobley, HL; Plaut, AG	1
Axon, A	1
Dagalp, K; Kadayifci, A; Kilinc, R; Uygun, A	1
Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM	1
Kerr, TG; Lambert, JR; Midolo, PD; Tee, W	1
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Papa, A; Pastorelli, A	1
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Gentiloni, N; Ojetti, V; Pastorelli, A; Pirozzi, G	1
Anti, M; Armuzzi, A; Branca, G; Candelli, M; Canducci, F; Fadda, G; Fedeli, G; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pastorelli, A; Pola, P; Torre, ES	1
Chan, FK; Chung, SC; Ling, TK; Suen, R; Sung, JJ; Wu, JC	1
Chey, WD; Chien, NN; Chung, NQ; Connor, BA; Henley, KS; Hoan, PQ; Hop, TV; Lak, BV; Long, T; Mao, HV; Perez-Perez, GI; Stone, CD; Thang, DM	1
Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R	1
Fox, JG; Marini, RP; McColm, AA; Taylor, NS; Williamson, R; Yan, L	1
Chmiela, M; Czkwianianc, E; Lawnik, M; Płaneta-Małecka, I; Rudnicka, W	1
Bilardi, C; Bisso, G; Borgonovo, G; Borro, P; De Salvo, L; Dulbecco, P; Mansi, C; Pivari, M; Raffaella Mele, M; Savarino, V; Tessieri, L; Vigneri, S; Zentilin, P	1
De Boer, WA; Jansen, JB; Van Oijen, AH; Verbeek, AL	1
Calvet, X; Gabriel, R; Gisbert, JP; González, L; Pajares, JM; Roqué, M	1
Buzás György, M; Illyés, G; Székely, E; Széles, I	1
Thomson, AB	1
Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R	1
Chiba, N	1
Akhunov, ED; Farztdinov, KM; Katayev, VA; Kazykhanov, NS; Khusnutdinov, SM; Nijevitch, AA; Sataev, VU	1
Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S	1
Mégraud, F; Roberts, P; Williamson, R	1
Chan, CK; Chu, KM; Fung, FM; Hu, WH; Lai, KC; Lam, SK; Lau, GK; Leung, SY; Wang, WH; Wong, BC; Wong, WM; Yuen, MF; Yuen, ST	1
Dashkova, S; Farztdinov, KM; Kazykhanov, NS; Nijevitch, AA; Sataev, VU	1
De Boer, WA; Jansen, JB; Janssen, MJ; Van Oijen, AH; Verbeek, AL	1
Kearney, DJ	1
Chejfec, G; O'Connell, S; Schnell, T; Seidel, J; Sonnenberg, A; Sontag, SJ	1
Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V	1
Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR	1
Hopkins, RJ	1
Dixon, CA; Hopkins, RJ; Meyer, JM; Siepman, NY; Silliman, NP; Sugg, JE	1
Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM	2
Chiba, N; Hunt, RH; Thomson, AB	1
Campo, SM; De Matthaeis, M; Febbraro, I; Hassan, C; Lorenzetti, R; Morini, S; Porto, D; Zullo, A	1
Bardhan, KD; Mitchell, TR; Morris, P; Morton, D; Perry, MJ; Roberts, PM; Rowland, A; Sanders, DS; Thompson, M	1
Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A	1
Beales, IL	1
Doulgeroglou, V; Kamberoglou, D; Patra, E; Polymeros, D; Sanidas, I; Savva, S; Tzias, V	1
Dudik, TV; Il'chenko, AA; Kaprel'yants, AS; Loginov, AS; Reshetnyak, VI; Vostroknutova, GN	1
Fang, XC; Hu, PJ; Li, ZS; Lu, H; Lu, XH; Xiao, SD; Zhang, DZ	1
De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A	1
Markova, T; Schwartz, K	1
Andriulli, A; Clemente, R; Festa, V; Merla, A; Perri, F; Quitadamo, M	1
Gisbert, JP; Pajares, JM	1
Brorson, O; Brorson, SH	1
Gómez Rodríguez, B; Hergueta Delgado, P; Herrerías Gutiérrez, JM; Mendoza Olivares, FJ; Pellicer Bautista, FJ; Rojas Feria, M; Romero Castro, R	1
Cuena Boy, R	1
Michetti, P; Suerbaum, S	1
Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M	1
Chan, CK; Fung, FM; Ho, VY; Hu, WH; Hung, WK; Lai, KC; Lam, SK; Szeto, ML; Tong, TS; Wong, BC; Wong, GS; Wong, WM; Xia, HH; Yip, AW; Yuen, MF	1
Kullavanijaya, P; Tangkijvanich, P; Thong-Ngam, D; Treeprasertsuk, S; Wisedopas, N	1
Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S	1
Berstad, A; Hatlebakk, JG; Olafsson, S	1
Hopkins, RJ; Meyer, JM	1
Chehter, EZ; Eisig, JN; Hashimoto, C; Laudanna, AA; Silva, FM	1
Danscher, G; Larsen, A; Martiny, N; Rungby, J; Stoltenberg, M	1
Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S	1
Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A	1
Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R	1
Bianchi Porro, G; Cucino, C; Parente, F	1
Candelli, M; Franceschi, F; Gasbarrini, G; Mettimano, M; Migneco, A; Montebelli, R; Ojetti, V; Savi, L; Specchia, L	1
de Boer, WA; Kuipers, EJ; Kusters, JG	1
Altintaş, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O	1
Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M	1
De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Panella, C; Vaira, D; Zullo, A	1
Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA	1
Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF	1
Calvet, X; Carpio, D; Fuentes, J; Gisbert, JP; Guardiola, J; Olivares, D; Tito, L; Tomas, A	1
Huang, JQ; Hunt, RH; Karlberg, J; Lam, SK; Wong, BC; Wong, WM; Zheng, GF	1
Calvet, X; Gisbert, JP; Gonzalez, L	1
Almeida, JR; Campos, LT; Guerrazzi, F; Lorena, SL; Mesquita, MA; Montes, CG; Zeitune, JM	1
Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P; Noble, S	1
Akarca, US; Aydin, A; Musoğlu, A; Onder, GF; Tekin, F; Tunçyürek, M	1
Lule, GN	1
Lee, KH; Tam, YH; Yeung, CK	1
Ge, R; He, QY; Huang, JD; Sun, H; Sun, X; Watt, RM; Wilcox, DE; Zhang, Y	1
Buzás, GM; Józan, J	2
Gisbert, JL; Gisbert, JP; Marcos, S; Moreno-Otero, R; Pajares, JM	1
Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Modeo, ME; Tursi, A	1
Fernández-Bermejo, M; Gisbert, JP; González-García, G; Mateos-Rodríguez, JM; Molina-Infante, J; Pérez-Gallardo, B; Prieto-Bermejo, AB; Robledo-Andrés, P	1
Mahachai, V; Thong-Ngam, D	1
Buzás, GM; Széles, I	1
Cakal, B; Kiliç, ZM; Köksal, AS; Kuran, S; Nadir, I; Ozin, YO; Sahin, B	1
Ran, ZH; Shen, J; Tong, JL; Xiao, SD	1
Akay, S; Akyildiz, M; Aydin, A; Musoglu, A; Tuncyurek, M	1
Huang, JD; Sun, HZ; Tanner, JA; Watt, RM	1
Demir, M; Gokturk, HS; Ozturk, NA; Serin, E; Yilmaz, U	1
Hibi, T; Nishizawa, T; Suzuki, H	1
Astegiano, M; Cisarò, F; De Angelis, C; Pellicano, R; Rizzetto, M; Saracco, G	1
Agarwal, A; Agrawal, GP; Agrawal, H; Jain, AK	1
Ateş, Y; Avşar, E; Aytuğ, N; Bektaş, A; Bölükbaş, C; Dinçer, D; Ellidokuz, E; Erzin, Y; Güliter, S; Kaymakoğlu, S; Kocakaya, O; Onuk, MD; Poturoğlu, S; Taşan, G; Tiftikçi, A; Türkay, C; Yıldırım, B; Yılmaz, U	1
Chan, JF; Cheng, T; Chik, KK; Jin, DY; Jin, L; Lee, AC; Li, H; Sun, H; Wang, R; Wang, S; Ye, ZW; Yuan, S; Yuen, KY; Zhang, AJ	1
Cha, JM; Jeon, JW; Kwak, MS; Yoon, JY	1

Reviews

26 review(s) available for ranitidine bismuth citrate and bismuth

Article	Year
Review article: safety of bismuth in the treatment of gastrointestinal diseases. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:4 Topics: Bismuth; Dyspepsia; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Peptic Ulcer; Ranitidine	1996
The actions of bismuth in the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1997, Volume: 11 Suppl 1 Topics: Anti-Bacterial Agents; Bismuth; Drug Synergism; Duodenum; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Organometallic Compounds; Ranitidine; Salicylates; Treatment Outcome	1997
The treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1997, Volume: 11 Suppl 1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma; Proton Pump Inhibitors; Ranitidine; Risk Factors; Stomach Neoplasms	1997
New developments in Helicobacter pylori eradication therapy. Scandinavian journal of gastroenterology. Supplement, 1997, Volume: 223 Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine	1997
Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1997, Volume: 48 Suppl 4 Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine	1997
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. Scandinavian journal of gastroenterology. Supplement, 1998, Volume: 225 Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine	1998
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine	1998
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12 Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Azithromycin; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine	1998
Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review. Helicobacter, 1999, Volume: 4, Issue:1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Pilot Projects; Ranitidine; Treatment Outcome	1999
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:8 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome	2000
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:9 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine	2000
Therapy for H. pylori infection. Current gastroenterology reports, 1999, Volume: 1, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine; Stomach Diseases	1999
Retreatment of Helicobacter pylori infection after initial treatment failure. The American journal of gastroenterology, 2001, Volume: 96, Issue:5 Topics: Anti-Ulcer Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine; Retreatment; Treatment Failure	2001
Helicobacter pylori and early duodenal ulcer status post-treatment: a review. Helicobacter, 2001, Volume: 6, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Odds Ratio; Omeprazole; Ranitidine; Research Design; Retrospective Studies; United States; United States Food and Drug Administration	2001
Ranitidine bismuth citrate. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2001, Volume: 15, Issue:6 Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine	2001
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Histamine H2 Antagonists; Humans; Metronidazole; Patient Care Planning; Penicillins; Proton Pumps; Ranitidine; Recurrence	2002
Helicobacter pylori infection. The New England journal of medicine, 2002, Oct-10, Volume: 347, Issue:15 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Proton Pump Inhibitors; Ranitidine; Salicylates; Virulence	2002
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:8 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine	2003
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline	2004
Treatment of H. pylori infection: a review. Current medicinal chemistry, 2005, Volume: 12, Issue:4 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin	2005
Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. World journal of gastroenterology, 2005, May-14, Volume: 11, Issue:18 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome	2005
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter, 2005, Volume: 10, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine	2005
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. World journal of gastroenterology, 2006, Sep-07, Volume: 12, Issue:33 Topics: Anti-Infective Agents; Bismuth; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pumps; Ranitidine; Time Factors; Treatment Outcome	2006
Nitrofuran-based regimens for the eradication of Helicobacter pylori infection. Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:10 Topics: Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Proton Pump Inhibitors; Ranitidine	2007
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome	2009
Helicobacter pylori eradication therapy. Future microbiology, 2010, Volume: 5, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome	2010

Trials

98 trial(s) available for ranitidine bismuth citrate and bismuth

Article	Year
The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity. Alimentary pharmacology & therapeutics, 1991, Volume: 5, Issue:5 Topics: Adolescent; Adult; Bismuth; Circadian Rhythm; Citrates; Double-Blind Method; Gastric Acid; Histamine H2 Antagonists; Humans; Male; Ranitidine	1991
Effect of administration of ranitidine bismuth citrate with food on the suppression and eradication of Helicobacter pylori in infected volunteers. The American journal of gastroenterology, 1995, Volume: 90, Issue:8 Topics: Adult; Bismuth; Breath Tests; Carbon Radioisotopes; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Food; Headache; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Incidence; Male; Ranitidine; Time Factors; Urea	1995
Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB). European journal of clinical pharmacology, 1994, Volume: 47, Issue:2 Topics: Adolescent; Adult; Anti-Ulcer Agents; Bismuth; Citrates; Double-Blind Method; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine	1994
Ranitidine bismuth citrate and ranitidine do not affect gastric emptying of a radio-labelled liquid meal. British journal of clinical pharmacology, 1994, Volume: 38, Issue:6 Topics: Adult; Bismuth; Citrates; Cross-Over Studies; Double-Blind Method; Food, Formulated; Gastric Emptying; Histamine H2 Antagonists; Humans; Male; Ranitidine; Technetium Tc 99m Pentetate	1994
Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury. Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:5 Topics: Adult; Aspirin; Bismuth; Citrates; Double-Blind Method; Duodenum; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Ranitidine	1993
Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. Gut, 1993, Volume: 34, Issue:3 Topics: Adult; Aged; Bismuth; Breath Tests; Citrates; Duodenal Ulcer; Food; Gastrins; Humans; Male; Middle Aged; Organometallic Compounds; Pepsinogens; Ranitidine; Time Factors	1993
Gastric persorption of bismuth from ranitidine bismuth citrate. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:4 Topics: Adult; Bismuth; Dyspepsia; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Microscopy, Electron; Ranitidine	1995
GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:5 Topics: Adult; Bismuth; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Logistic Models; Male; Middle Aged; Ranitidine; Treatment Outcome	1995
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine; Recurrence	1996
The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine	1996
Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate. British journal of clinical pharmacology, 1996, Volume: 42, Issue:2 Topics: Adult; Area Under Curve; Bismuth; Half-Life; Histamine H2 Antagonists; Humans; Male; Metabolic Clearance Rate; Ranitidine	1996
Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate. British journal of clinical pharmacology, 1996, Volume: 42, Issue:2 Topics: Adult; Area Under Curve; Bismuth; Half-Life; Histamine H2 Antagonists; Humans; Male; Metabolic Clearance Rate; Middle Aged; Ranitidine	1996
Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Antacids; Bismuth; Dose-Response Relationship, Drug; Double-Blind Method; Food; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Peptones; Placebos; Ranitidine; Stimulation, Chemical	1996
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine	1997
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut, 1997, Volume: 41, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Ranitidine; Treatment Outcome; Wound Healing	1997
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:4 Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Pyloric Antrum; Ranitidine	1997
Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tetracycline	1997
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. The American journal of gastroenterology, 1998, Volume: 93, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline	1998
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. The American journal of gastroenterology, 1998, Volume: 93, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome	1998
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:5 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine	1998
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing	1997
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. The American journal of gastroenterology, 1998, Volume: 93, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Stomach Ulcer; Tetracycline; Treatment Outcome	1998
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole	1998
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole	1998
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Ranitidine; Stomach Ulcer	1998
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method	1998
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine	1998
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. The American journal of gastroenterology, 1998, Volume: 93, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Time Factors; Treatment Failure	1998
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:8 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome	1998
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer. Helicobacter, 1998, Volume: 3, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Recurrence; Treatment Outcome	1998
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:11 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine	1998
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12 Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Azithromycin; Bismuth; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine	1998
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome; Urea	1999
One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. The American journal of gastroenterology, 1999, Volume: 94, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Tetracycline	1999
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:2 Topics: Adolescent; Adult; Aged; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Proton Pump Inhibitors; Ranitidine	1999
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer	1999
Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Ranitidine; Tetracycline; Urea	1999
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. The American journal of gastroenterology, 1999, Volume: 94, Issue:4 Topics: Adult; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Ranitidine; Time Factors	1999
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:4 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine	1999
Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Prospective Studies; Ranitidine; Spiramycin	1999
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. The American journal of gastroenterology, 1999, Volume: 94, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Ranitidine; Urea	1999
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. Helicobacter, 1999, Volume: 4, Issue:2 Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ranitidine	1999
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome	1999
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Ranitidine	1999
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome	1999
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. The American journal of gastroenterology, 1999, Volume: 94, Issue:10 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine; Turkey	1999
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:10 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure	1999
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. Digestive diseases and sciences, 1999, Volume: 44, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tinidazole; Treatment Outcome; Urea	1999
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Prospective Studies; Ranitidine; Tinidazole; Urea	2000
Efficacy of a multistep strategy for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1 Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole; Treatment Failure	2000
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Salvage Therapy	2000
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A; Male; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Urease; Vietnam	2000
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method	2000
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. American journal of veterinary research, 1999, Volume: 60, Issue:10 Topics: Animals; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Helicobacter; Helicobacter Infections; Ovariectomy; Ranitidine; Time Factors	1999
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:7 Topics: Adult; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome	2000
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. Orvosi hetilap, 2000, Jul-30, Volume: 141, Issue:31 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome	2000
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome	2000
Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:11 Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Ranitidine; Tinidazole	2000
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo. Helicobacter, 2000, Volume: 5, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine	2000
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Ranitidine; Treatment Outcome; Urea	2001
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. The American journal of gastroenterology, 2001, Volume: 96, Issue:5 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Penicillins; Ranitidine; Veterans	2001
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. Clinical therapeutics, 2001, Volume: 23, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome	2001
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea	2001
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication. Helicobacter, 2001, Volume: 6, Issue:2 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine	2001
A triple therapy regimen after failed Helicobacter pylori treatments. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Tetracycline; Tinidazole; Urea; Urease	2001
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome; Urea; Urease	2001
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days]. Anales de medicina interna (Madrid, Spain : 1984), 2001, Volume: 18, Issue:7 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine	2001
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:9 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome	2001
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:11 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies	2001
One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:12 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Diarrhea; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exanthema; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Prospective Studies; Pruritus; Ranitidine; Tetracycline; Treatment Outcome; Vomiting	2001
Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:8 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome	2001
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection. Helicobacter, 2002, Volume: 7, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure	2002
Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection. Revista espanola de enfermedades digestivas, 2002, Volume: 94, Issue:1 Topics: Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine	2002
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. Wiener klinische Wochenschrift, 2002, Jun-28, Volume: 114, Issue:12 Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome	2002
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:12 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Treatment Outcome	2002
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:10 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Stomach; Thailand; Treatment Outcome	2002
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:12 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline	2002
Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers. Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:12 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenitis; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Oxytetracycline; Peptic Ulcer; Ranitidine; Spiramycin; Time Factors	2002
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17, Issue:9 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea	2003
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea	2003
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments. Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome	2003
Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter, 2003, Volume: 8, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Bismuth; Blood Pressure; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Male; Middle Aged; Prevalence; Ranitidine	2003
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:2 Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome	2004
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10 Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome	2004
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:4 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey	2005
7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure. Alimentary pharmacology & therapeutics, 2005, May-15, Volume: 21, Issue:10 Topics: Adult; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure	2005
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer. World journal of gastroenterology, 2005, Jun-21, Volume: 11, Issue:23 Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome	2005
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial. BMJ (Clinical research ed.), 2006, Jan-28, Volume: 332, Issue:7535 Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Patient Acceptance of Health Care; Peptic Ulcer; Quality of Life; Ranitidine	2006
Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Alimentary pharmacology & therapeutics, 2006, Jul-01, Volume: 24, Issue:1 Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Prospective Studies; Ranitidine	2006
Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Helicobacter, 2007, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Ranitidine; Treatment Failure; Treatment Outcome	2007
Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Medical science monitor : international medical journal of experimental and clinical research, 2007, Volume: 13, Issue:4 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole	2007
First-line triple therapy with levofloxacin for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 2007, Aug-01, Volume: 26, Issue:3 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Ranitidine; Treatment Outcome	2007
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection. Journal of gastroenterology, 2008, Volume: 43, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Urea	2008
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection. Digestive diseases and sciences, 2008, Volume: 53, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Middle Aged; Moxifloxacin; Pilot Projects; Prospective Studies; Quinolines; Ranitidine; Treatment Outcome; Young Adult	2008
The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication. European journal of internal medicine, 2009, Volume: 20, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Tetracyclines; Treatment Outcome	2009
Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. The American journal of the medical sciences, 2009, Volume: 338, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Ranitidine	2009
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2013, Volume: 24, Issue:4 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome; Young Adult	2013
Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of Helicobacter pylori Eradication: A Prospective, Randomized, Controlled and Open-Label Study. The Tohoku journal of experimental medicine, 2021, Volume: 255, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Treatment Failure; Treatment Outcome	2021

Other Studies

42 other study(ies) available for ranitidine bismuth citrate and bismuth

Article	Year
Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:3 Topics: Animals; Anti-Ulcer Agents; Bismuth; Citrates; Dogs; Ethanol; Female; Ferrets; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Indomethacin; Isoenzymes; Male; Microbial Sensitivity Tests; Organometallic Compounds; Pepsin A; Ranitidine; Rats; Stomach Ulcer	1993
Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3 Topics: Animals; Anti-Ulcer Agents; Bismuth; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Drug Combinations; Female; Gastric Acid; Helicobacter pylori; Histamine H2 Antagonists; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred ICR; Organometallic Compounds; Pepsin A; Ranitidine; Solubility; Spectrophotometry, Infrared; X-Ray Diffraction	1996
Practice guidelines for treatment of peptic ulcer disease. JAMA, 1996, Oct-09, Volume: 276, Issue:14 Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine	1996
Pylorid, H. pylori and peptic ulcer. Drug and therapeutics bulletin, 1996, Volume: 34, Issue:9 Topics: Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Randomized Controlled Trials as Topic; Ranitidine	1996
Ranitidine bismuth citrate therapy. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6 Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine	1996
Modeling of trough plasma bismuth concentrations. Journal of pharmacokinetics and biopharmaceutics, 1997, Volume: 25, Issue:1 Topics: Bayes Theorem; Bismuth; Histamine H2 Antagonists; Humans; Male; Models, Biological; Ranitidine	1997
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics. Helicobacter, 1997, Volume: 2, Issue:1 Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Ranitidine; Streptomycin	1997
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Revue medicale de Liege, 1998, Volume: 53, Issue:1 Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Receptors, Histamine H2; Stomach Ulcer	1998
Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate. The Journal of pharmacy and pharmacology, 1998, Volume: 50, Issue:3 Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Bismuth; Brain; Histamine H2 Antagonists; Kidney; Liver; Lung; Male; Organometallic Compounds; Ranitidine; Rats; Rats, Wistar	1998
Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:3 Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Synergism; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ranitidine	1998
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:2 Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tetracycline	1999
Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1999, Volume: 12, Issue:1 Topics: Anti-Ulcer Agents; Bismuth; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Ranitidine	1999
Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:5 Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Tetracycline	1999
Effects of ranitidine bismuth citrate on Helicobacter pylori motility, morphology and survival. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:6 Topics: Anti-Ulcer Agents; Bismuth; Helicobacter pylori; Humans; Microscopy, Electron; Organometallic Compounds; Ranitidine	1999
Effect of ranitidine bismuth citrate on the phospholipase A2 activity of Naja naja venom and Helicobacter pylori: a biochemical analysis. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7 Topics: Animals; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Elapid Venoms; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Phospholipases A; Phospholipases A2; Ranitidine	1999
Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions. Helicobacter, 1999, Volume: 4, Issue:3 Topics: Bacterial Proteins; Bismuth; Carrier Proteins; Cation Transport Proteins; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Membrane Proteins; Metals, Heavy; Microbial Sensitivity Tests; Organometallic Compounds; Proteins; Ranitidine	1999
Treatment of Helicobacter pylori: where are we now? What are the key questions? European journal of gastroenterology & hepatology, 1999, Volume: 11 Suppl 2 Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Treatment Outcome; United Kingdom	1999
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:11 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Ranitidine; Tetracycline	1999
[IgG and IgA immunoglobulins in helicobacter pylori infections of children with chronic dyspepsia before and after two week triple drug therapy]. Medycyna doswiadczalna i mikrobiologia, 1999, Volume: 51, Issue:1-2 Topics: Adolescent; Amoxicillin; Bismuth; Blotting, Western; Child; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monitoring, Physiologic; Ranitidine; Serologic Tests	1999
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2000, Volume: 14, Issue:10 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Ranitidine; Salicylates	2000
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication. Journal of clinical gastroenterology, 2001, Volume: 32, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine	2001
Optimal strategy of treatment of Helicobacter pylori infection: renaissance of antisecretory drugs? The American journal of gastroenterology, 2001, Volume: 96, Issue:3 Topics: Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine	2001
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Patient Care Planning; Penicillins; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome	2001
In search of the Holy Grail of Heliocobacter pylori remedies. Helicobacter, 2001, Volume: 6, Issue:2 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Humans; Metronidazole; Pilot Projects; Ranitidine; Spain	2001
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. BMC gastroenterology, 2001, Volume: 1 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Ranitidine; Treatment Outcome	2001
Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication. Bulletin of experimental biology and medicine, 2001, Volume: 132, Issue:2 Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Bismuth; DNA Fingerprinting; Duodenal Ulcer; Female; Flagellin; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Ranitidine; Recurrence; Restriction Mapping; Species Specificity; Time Factors; Urease	2001
What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt? The Journal of family practice, 2002, Volume: 51, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Costs; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Analysis as Topic; Proton Pump Inhibitors; Ranitidine	2002
Susceptibility of motile and cystic forms of Borrelia burgdorferi to ranitidine bismuth citrate. International microbiology : the official journal of the Spanish Society for Microbiology, 2001, Volume: 4, Issue:4 Topics: Anti-Bacterial Agents; Bismuth; Borrelia burgdorferi; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Movement; Ranitidine; Time Factors	2001
[Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay]. Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:8 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine	2002
Helicobacter pylori. The New England journal of medicine, 2003, Jan-23, Volume: 348, Issue:4 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine	2003
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients. Sao Paulo medical journal = Revista paulista de medicina, 2003, Jan-02, Volume: 121, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine	2003
Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. Pharmacology & toxicology, 2003, Volume: 93, Issue:2 Topics: Absorption; Administration, Oral; Animals; Bismuth; Dose-Response Relationship, Drug; Female; Intestinal Absorption; Kidney; Liver; Lysosomes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microscopy, Electron; Organometallic Compounds; Ranitidine; Staining and Labeling; Time Factors	2003
Information from your family doctor. Ulcers and Helicobacter pylori infection. American family physician, 2003, Nov-15, Volume: 68, Issue:10 Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Family Practice; Helicobacter Infections; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine	2003
Sequential therapy for H. pylori: an 'aberrant' therapy ready for general use. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:12 Topics: Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine	2004
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Ranitidine; Treatment Outcome	2005
Helicobacter pylori eradication in peptic dyspepsia. East African medical journal, 2005, Volume: 82, Issue:12 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine	2005
Thermodynamic and kinetic aspects of metal binding to the histidine-rich protein, Hpn. Journal of the American Chemical Society, 2006, Sep-06, Volume: 128, Issue:35 Topics: Amino Acid Sequence; Bacterial Proteins; Binding, Competitive; Bismuth; Copper Sulfate; Edetic Acid; Escherichia coli; Hydrogen-Ion Concentration; Kinetics; Metals; Molecular Sequence Data; Nickel; Protein Binding; Proteins; Ranitidine; Thermodynamics; Zinc Sulfate	2006
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2006, Volume: 89 Suppl 3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Ranitidine; Tetracycline; Treatment Failure	2006
Determination of the functions of the putative metal-binding domain of the SCV helicase. Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15 Suppl 6 Topics: Antiviral Agents; Binding Sites; Bismuth; DNA Helicases; Ranitidine; Severe acute respiratory syndrome-related coronavirus; Zinc	2009
Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment. Panminerva medica, 2011, Volume: 53, Issue:2 Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Treatment Outcome	2011
Double-liposome-based dual-drug delivery system as vectors for effective management of peptic ulcer. Journal of liposome research, 2012, Volume: 22, Issue:3 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Stability; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Liposomes; Male; Microbial Sensitivity Tests; Particle Size; Peptic Ulcer; Ranitidine; Rats	2012
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nature microbiology, 2020, Volume: 5, Issue:11 Topics: Animals; Antiviral Agents; Betacoronavirus; Bismuth; Chemokines; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Disease Models, Animal; HEK293 Cells; Humans; Lung; Mesocricetus; Pandemics; Pneumonia, Viral; Ranitidine; RNA Helicases; SARS-CoV-2; Vero Cells; Viral Load; Virus Replication	2020